<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國(guó)服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028123Fruquintinib 1194506-26-7

    Fruquintinib 1194506-26-7

    簡(jiǎn)要描述:Fruquintinib 1194506-26-7
    Fruquintinib (HMPL-013) is a small molecule vascular endothelial growth factor receptors inhibitor.

    • 產(chǎn)品型號(hào):abs47028123
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-19
    • 訪  問  量:587

    詳細(xì)介紹

    品牌absinCAS1194506-26-7
    分子式C21H19N3O5純度99%
    分子量393.39貨號(hào)abs47028123
    規(guī)格10mg供貨周期現(xiàn)貨
    主要用途is a small molecule vascular endothelial應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Fruquintinib 1194506-26-7

    產(chǎn)品描述
    描述
    Fruquintinib (HMPL-013) is a small molecule vascular endothelial growth factor receptors inhibitor.
    純度
    99%
    儲(chǔ)存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    外觀
    white powder
    可溶性/溶解性
    10 mM in DMSO
    生物活性
    靶點(diǎn)
    VEGFR3 ,VEGFR1 ,VEGFR2
    In vitro(體外研究)
    In in vitro enzymatic and cellular assays, Fruquintinib inhibits VEGFR family kinases and suppressed VEGF/VEGFR cell signaling in human umbilical vein endothelial cell (HUVEC) and human lymphatic endothial cell (HLEC) with IC50 at low nanomolar level. Few kinases are inhibited other than VEGFRs in a panel of 253 kinases test. Fruquintinib is a highly potent inhibitor of VEGF-induced angiogenesis.
    In vivo(體內(nèi)研究)
    Fruquintinib demonstrates favorable pharmacokinetic profile in multiple animal species, oral administration of fruquintinib strongly suppressed VEGF-induced VEGFR2 phosphorylation in the lung tissue in mice. The extent and duration of the inhibition of VEGFR2 phosphorylation correlated well with drug exposures. The strong anti-angiogenic effect resulted in robust anti-tumor efficacy in a number of human tumor xenograft models with good dose response.
    研究領(lǐng)域
    研究領(lǐng)域
    CancerCancer MetabolismResponse to hypoxia
    CancerOncoproteins/suppressorsOncoproteinsGrowth factor receptors
    CardiovascularAngiogenesisEndothelial Cell Markers
    CardiovascularCardiovascular MarkersCell MarkersEndothelial Cells
    MetabolismTypes of diseaseCancer
    MetabolismPathways and ProcessesMetabolism processesHypoxia
    MicrobiologyInterspecies InteractionHost Virus Interaction
    NeuroscienceDevelopment
    NeuroscienceProcesses
    Signal TransductionProtein PhosphorylationTyrosine KinasesReceptor Tyrosine Kinases
    Stem CellsEndothelial ProgenitorsEndothelial Markers
    Stem CellsHematopoietic ProgenitorsSurface Molecules
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Fruquintinib 1194506-26-7溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說明:

    • 驗(yàn)證碼:

      請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
    歡迎您關(guān)注我們的微信公眾號(hào)
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    无码操逼视频观看 | 麻豆传媒操逼表情包 | 毛片A区| 成人a一级毛片免费看 | 一区二区三区四区精品久久 |